PURE Bioscience Sets Q3 Results Conference Call To Update Progress Of FDA Approved PURE Control Antimicrobial And The Company’s Food Safety Solutions Strategy

SAN DIEGO--(BUSINESS WIRE)--PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented silver dihydrogen citrate (SDC) antimicrobial, announced today that on June 9, 2016 the Company will file its Form 10-Q shortly after the close of the market and host an investor conference call that day at 1:30pm PDT (4:30pm EDT) to review fiscal third quarter financial results.